Date: June 01, 2026
Board Meeting Outcomes
This document serves as a corrigendum to the intimation submitted to stock exchanges on May 27, 2026 regarding the outcome of the board meeting of Material Unlisted Subsidiary Natural Biogenex Private Limited, which detailed approval of a Rights Issue.
The correction addresses a typographical/clerical error in the previously disclosed information:
- Original incorrect number of equity shares: 11,11,200
- Corrected number of equity shares being offered: 11,11,205 Equity Shares of ₹10 each
- Original incorrect gross proceeds figure: Not explicitly stated but implied incorrect
- Corrected total gross proceeds: ₹1,11,12,050 (Rupees One Crore Eleven Lakh Twelve Thousand and Fifty Only)
All other contents and details specified in the original intimation dated May 27, 2026 remain unchanged and valid.
KMP / Board / Auditor Changes
Not Specified
Dividend Declaration or Non-Declaration
Not Specified
Financial Results (Standalone & Consolidated)
Not Specified
Disinvestment / Strategic Actions
Not Specified
Other Operational / Legal / Strategic Disclosures
The company requests the stock exchanges to make this correction on their records and update accordingly.